Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | SAM | Class A Common | Options Exercise | $37.2K | +119 | +2.11% | $312.56 | 5.77K | Jun 7, 2021 | Direct | F1, F2 |
transaction | SAM | Class A Common | Options Exercise | $67.3K | +352 | +6.11% | $191.10 | 6.12K | Jun 7, 2021 | Direct | F1, F2 |
transaction | SAM | Class A Common | Sale | -$387K | -352 | -5.75% | $1,100.21 | 5.77K | Jun 7, 2021 | Direct | F1, F2 |
transaction | SAM | Class A Common | Sale | -$131K | -119 | -2.06% | $1,100.21 | 5.65K | Jun 7, 2021 | Direct | F1, F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | SAM | Stock Option (Right to Buy) | Options Exercise | $0 | -119 | -25% | $0.00 | 357 | Jun 7, 2021 | Class A Common | 119 | $312.56 | Direct | F1, F3 |
transaction | SAM | Stock Option (Right to Buy) | Options Exercise | $0 | -352 | -24.96% | $0.00 | 1.06K | Jun 7, 2021 | Class A Common | 352 | $191.10 | Direct | F1, F4 |
Id | Content |
---|---|
F1 | The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 6, 2021. |
F2 | The shares reported include 3,362 shares of restricted stock subject to vesting conditions. |
F3 | The Performance-Based Stock Options were granted pursuant to the Issuer's Restated Employee Equity Incentive Plan ("EEIP"). The extent to which the options were exercisable was dependent upon the Company achieving certain compounded annual growth rate targets based on net revenue growth in Fiscal Year 2020 over Fiscal Year 2018. The determination that these options vested was made by the Compensation Committee in February 2021. |
F4 | The Performance-Based Stock Options were granted pursuant to the Issuer's EEIP. The extent to which the options were exercisable was dependent upon the Company achieving certain compounded annual growth rate targets based on net revenue growth in Fiscal Year 2019 over Fiscal Year 2017. The determination that the options vested was made by the Compensation Committee in February 2020. |